MYR 4.15
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.30 MYR | -31.82% |
2022 | 0.44 MYR | 4.76% |
2021 | 0.42 MYR | 147.06% |
2020 | 0.17 MYR | -15.0% |
2019 | 0.20 MYR | 25.0% |
2018 | 0.16 MYR | 45.45% |
2017 | 0.11 MYR | 17.77% |
2016 | 0.09 MYR | 59.39% |
2015 | 0.06 MYR | 632.5% |
2014 | 0.01 MYR | -81.35% |
2013 | 0.04 MYR | 48.44% |
2012 | 0.03 MYR | 217.58% |
2011 | 0.01 MYR | 152.6% |
2010 | -0.02 MYR | -118.27% |
2009 | 0.09 MYR | 27.97% |
2008 | 0.07 MYR | 12.12% |
2007 | 0.07 MYR | -61.18% |
2006 | 0.17 MYR | 110.66% |
2005 | 0.08 MYR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q4 | 0.08 MYR | 82.65% |
2023 Q3 | 0.05 MYR | -41.12% |
2023 FY | - MYR | -31.82% |
2023 Q2 | 0.08 MYR | -14.98% |
2023 Q1 | 0.09 MYR | 4.19% |
2022 Q1 | 0.12 MYR | 9.09% |
2022 Q2 | 0.11 MYR | -8.33% |
2022 Q3 | 0.12 MYR | 9.09% |
2022 Q4 | 0.09 MYR | -26.33% |
2022 FY | - MYR | 4.76% |
2021 Q1 | 0.10 MYR | 18.62% |
2021 Q3 | 0.12 MYR | 27.66% |
2021 Q4 | 0.11 MYR | -8.33% |
2021 FY | - MYR | 147.06% |
2021 Q2 | 0.09 MYR | -6.0% |
2020 Q1 | 0.02 MYR | -69.23% |
2020 Q3 | 0.04 MYR | 93.15% |
2020 FY | - MYR | -15.0% |
2020 Q4 | 0.08 MYR | 99.29% |
2020 Q2 | 0.02 MYR | 30.36% |
2019 Q4 | 0.05 MYR | 3.8% |
2019 FY | - MYR | 25.0% |
2019 Q3 | 0.05 MYR | -17.3% |
2019 Q1 | 0.04 MYR | -21.37% |
2019 Q2 | 0.06 MYR | 72.83% |
2018 Q2 | 0.03 MYR | -18.35% |
2018 FY | - MYR | 45.45% |
2018 Q4 | 0.05 MYR | 26.15% |
2018 Q3 | 0.04 MYR | 6.92% |
2018 Q1 | 0.04 MYR | 1.19% |
2017 Q3 | 0.03 MYR | -12.93% |
2017 Q2 | 0.03 MYR | 83.24% |
2017 FY | - MYR | 17.77% |
2017 Q1 | 0.02 MYR | 19.31% |
2017 Q4 | 0.04 MYR | 52.17% |
2016 Q3 | 0.03 MYR | -20.28% |
2016 FY | - MYR | 59.39% |
2016 Q4 | 0.01 MYR | -58.09% |
2016 Q2 | 0.04 MYR | 4240.0% |
2016 Q1 | 0.00 MYR | -95.37% |
2015 Q2 | 0.00 MYR | -83.58% |
2015 Q1 | 0.03 MYR | 364.41% |
2015 Q3 | 0.01 MYR | 13.33% |
2015 Q4 | 0.02 MYR | 323.53% |
2015 FY | - MYR | 632.5% |
2014 Q4 | 0.01 MYR | 5.36% |
2014 Q3 | 0.01 MYR | -67.82% |
2014 FY | - MYR | -81.35% |
2014 Q2 | 0.02 MYR | 183.25% |
2014 Q1 | -0.02 MYR | -177.99% |
2013 Q2 | 0.00 MYR | 100.4% |
2013 Q3 | 0.04 MYR | 41200.0% |
2013 Q4 | 0.03 MYR | -35.11% |
2013 FY | - MYR | 48.44% |
2013 Q1 | -0.03 MYR | -155.36% |
2012 Q3 | 0.03 MYR | 293.33% |
2012 FY | - MYR | 217.58% |
2012 Q1 | -0.03 MYR | -197.78% |
2012 Q4 | 0.05 MYR | 57.59% |
2012 Q2 | -0.02 MYR | 51.46% |
2011 Q1 | -0.00 MYR | -132.47% |
2011 Q2 | -0.01 MYR | -440.0% |
2011 Q4 | 0.03 MYR | 586.15% |
2011 FY | - MYR | 152.6% |
2011 Q3 | -0.01 MYR | 51.85% |
2010 FY | - MYR | -118.27% |
2010 Q2 | -0.02 MYR | 0.0% |
2010 Q3 | -0.02 MYR | 20.53% |
2010 Q4 | 0.01 MYR | 150.99% |
2009 Q4 | 0.03 MYR | 75.72% |
2009 Q3 | 0.02 MYR | 0.0% |
2009 FY | - MYR | 27.97% |
2008 FY | - MYR | 12.12% |
2007 FY | - MYR | -61.18% |
2006 FY | - MYR | 110.66% |
2005 FY | - MYR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Duopharma Biotech Berhad | 0.05 MYR | -446.448% |